AIMS Institute offers Galleri cancer screening blood test

AIMS Institute offers Galleri cancer screening blood testGet Ahead of Cancer When it’s Most Treatable

 

What is the importance of early detection?

  • Finding cancer early creates the best chance for successful treatment.
  • Today, there are 5 recommended cancer screening tests that together only account for 1 in 4 diagnosed cancers in patients over 50 years of age.
  • When cancers are diagnosed early before they have had a chance to spread, the overall 5-year survival rate is 4x higher than when diagnosed in later stages.

 

What is the Galleri Multi-Cancer Early Detection test?

  • The Galleri test screens for a signal shared by multiple cancers, many without recommended screening.
  • If a cancer signal is detected, the results predict where in the body the cancer is coming from to help guide your next steps.

 

Watch this video to learn more about how the Galleri test works:

https://youtu.be/ZqkuKb9yqVA?feature=shared

 

Who can benefit from the Galleri test?

  • The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older.
  • It is intended to be used in addition to and not replace other cancer screening tests your healthcare provider recommends.

 

Listen to Roger’s Galleri story about his early pancreatic cancer diagnosis: https://youtu.be/nOAgCqOu6NY?feature=shared

 

It is important to know that:

  • The Galleri test does not detect all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur.
  • It should be used in addition to guideline-recommended cancer screenings such as mammography, colonoscopy, PSA, or cervical cancer screening.

 

AIMS Institute is proud to offer the Galleri® multi-cancer early detection test.

Our practice has a discounted price of $849 ($949 list price). Flexible payment options, such as 0% interest up to 12 months are also available. You may be able to use FSA or HSA funds to cover the cost of the test. The Galleri test is not covered by most health insurance plans.

 

Call us today at (206) 420-1321 and let us know if you want to take the Galleri test so we can be sure to have a kit reserved for you!

Latest Blog Posts

6 Lessons From My Patients, Who Prepared Me for Cancer

6 Lessons From My Patients, Who Prepared Me for Cancer

Mar . 10 . 2026 Kidney Cancer Association This is a guest post by Alena Guggenheim, N.D., Assistant Professor of Anesthesiology and Perioperative Medicine at the Oregon Health & Science University’s School of Medicine in Portland, Oregon. Dr. Guggenheim was diagnosed with a malignant sarcoma in late 2024 after discovering a large mass on her kidney. I had been feeling slightly off for a week, a subtle wobble in my vision, a quickening of my heart I couldn’t quite name. Then, one night at 3 a.m., I woke dripping in sweat, with the worst headache of my life. I tried to ...

Read More
Welcoming Dr. Rachel Caplan-Erickson, ND, LAc to AIMS Institute

Welcoming Dr. Rachel Caplan-Erickson, ND, LAc to AIMS Institute

Integrative Primary Care | Root-Cause Medicine | Whole-Person Healing We are honored and delighted to welcome Dr. Rachel Caplan-Erickson, ND, LAc to the AIMS Institute team. With over 14 years of clinical experience, Dr. Rachel brings a deeply integrative, root-cause approach to primary care that bridges modern diagnostics with time-honored healing traditions. Her work embodies what AIMS Institute stands for: comprehensive, compassionate, whole-person medicine. A Truly Integrative Approach to Primary Care Dr. Rachel is a licensed naturopathic physician and acupuncturist who provides comprehensive primary care through a uniquely integrative lens. She combines advanced laboratory testing and modern medical diagnostics with ...

Read More
Ketamine assisted psychotherapy in postpartum mood and anxiety disorders: a limited case series

Ketamine assisted psychotherapy in postpartum mood and anxiety disorders: a limited case series

Alka Christnacht1Therry Rose Eparwa1,2Emily Whinkin2*Sunil Aggarwal2,3 The postpartum period is notorious for rapid and profound changes for birthing individuals and their families. Significant shifts to hormonal and physical health, routines and family roles, and the salience of personal and community risk factors all contribute to potential psychiatric and psychological distress for parents, sometimes diagnosed as a postpartum mood or anxiety disorder (PMAD). Existing pharmacologic treatment modalities for PMADs do not comprehensively address the profound shifts of the postpartum period, often inadequate at reaching peak therapeutic efficacy in a shorter time frame, in patient accessibility, or offering sustained benefit. Ketamine assisted ...

Read More

Accessibility Tools

Increase TextIncrease Text
Decrease TextDecrease Text
GrayscaleGrayscale
Invert Colors
Readable FontReadable Font
Reset
Call Us Text Us